Chiang J - Search Results

1

Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy.

Chan A, Chen C, Chiang J, Tan SH, Ng R. Chan A, et al. Among authors: chiang j. Support Care Cancer. 2012 Jul;20(7):1525-32. doi: 10.1007/s00520-011-1241-6. Epub 2011 Aug 5. Support Care Cancer. 2012. PMID: 21818641

2

Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patients.

Chan A, Leng XZ, Chiang JY, Tao M, Quek R, Tay K, Lim ST. Chan A, et al. Asia Pac J Clin Oncol. 2011 Mar;7(1):75-81. doi: 10.1111/j.1743-7563.2010.01355.x. Epub 2010 Dec 22. Asia Pac J Clin Oncol. 2011. PMID: 21332654 Clinical Trial.

3

Breakthrough febrile neutropenia and associated complications among elderly cancer patients receiving myelosuppressive chemotherapy for solid tumors and lymphomas.

Chan A, Lee CP, Chiang J, Ng R. Chan A, et al. Among authors: chiang j. Support Care Cancer. 2013 Aug;21(8):2137-43. doi: 10.1007/s00520-013-1768-9. Epub 2013 Mar 8. Support Care Cancer. 2013. PMID: 23471537

4

Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients.

Chan A, Soh D, Ko Y, Huang YC, Chiang J. Chan A, et al. Among authors: chiang j. Support Care Cancer. 2014 Jul;22(7):1875-81. doi: 10.1007/s00520-014-2160-0. Epub 2014 Feb 22. Support Care Cancer. 2014. PMID: 24557010

5

Costs and length of stay of drug-related hospital admissions in cancer patients.

Ko Y, Gwee YS, Huang YC, Chiang J, Chan A. Ko Y, et al. Among authors: chiang j. Clin Ther. 2014 Apr 1;36(4):588-92. doi: 10.1016/j.clinthera.2014.02.014. Epub 2014 Mar 14. Clin Ther. 2014. PMID: 24636525

6

Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients.

Shih V, Chiang JY, Chan A. Shih V, et al. Among authors: chiang jy. Ann Oncol. 2009 Apr;20(4):752-7. doi: 10.1093/annonc/mdn659. Epub 2009 Jan 15. Ann Oncol. 2009. PMID: 19150956 Free article.

7

Clinical pharmacy services and research for lymphoma patients at a cancer center.

Chan A, Shih V, Chiang J, Chew L, Tay K, Quek R, Tao M, Lim ST. Chan A, et al. Among authors: chiang j. J Oncol Pharm Pract. 2013 Mar;19(1):24-30. doi: 10.1177/1078155212449031. Epub 2012 Jun 15. J Oncol Pharm Pract. 2013. PMID: 22706787

8

A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer center.

Chiang J, Chan A, Shih V, Hee SW, Tao M, Lim ST. Chiang J, et al. Int J Hematol. 2010 Jun;91(5):826-30. doi: 10.1007/s12185-010-0583-z. Epub 2010 May 13. Int J Hematol. 2010. PMID: 20461562

9

Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: a case series and literature review.

Chiang J, Chan A, Lian T, Tay K, Quek R, Tao M, Lim ST. Chiang J, et al. Asia Pac J Clin Oncol. 2011 Dec;7(4):351-6. doi: 10.1111/j.1743-7563.2011.01464.x. Asia Pac J Clin Oncol. 2011. PMID: 22151984 Review.

10

Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.

Chan A, Chiang J, Lew KY, Chay WY. Chan A, et al. Among authors: chiang j. J Clin Oncol. 2011 Jun 1;29(16):e489; author reply e490-1. doi: 10.1200/JCO.2011.34.9431. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21482983 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,722 results

Search Page

Filters